Low dose estrogen replacement therapy in early postmenopausal women effect on urinary magnesium and calcium: Creatinine ratios

B. Kaplan*, A. Neri, E. Kitai, Y. Pardo, M. Blum, J. Friedman

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

The purpose of this study was to investigate whether treatment for prevention of osteoporosis by means of postmenopausal hormone replacement therapy (HRP) and daily exercise, had any effect on ratios of urinary calcium:creatinine (Ca:Cre) and magnesium:creatinine (Mg:Cre). A group of 33 early postmenopausal women (menopause onset 12-18 months previously), mean age 49.12 years, were treated during 6 months with low doses of transdermal estrogen (Estraderm TTS 25μg, Ciba-Geigy) opposed by oral progestogen (Duphaston 10 mg, 10 days every month), and daily exercise (walking for 1 hour). Despite HRT's statistically significant lowering effect on Ca:Cre and Mg:Cre ratios, these returned to pretreatment levels 6 months after withdrawal from HRT. The mechanism by which HRT affects magnesiuria and calciuria is discussed.

Original languageEnglish
Pages (from-to)170-172
Number of pages3
JournalClinical and Experimental Obstetrics and Gynecology
Volume21
Issue number3
StatePublished - 1994

Fingerprint

Dive into the research topics of 'Low dose estrogen replacement therapy in early postmenopausal women effect on urinary magnesium and calcium: Creatinine ratios'. Together they form a unique fingerprint.

Cite this